We are actively engaged in the fight against COVID-19 by manufacturing various products that aid in the help to save lives, including our anti-fog coatings for PPE, our anti-microbial hydrophilic coatings for medical devices, and our hand sanitizers. We are making our sanitizer products available, under our Hydromer® First Responder™ brand that has been proven to kill COVID or privately labeled under your brand, to ensure getting hand sanitizers to end users in the fastest way possible, during the current extreme demand and short supply of those critical products. We have pledged to donate hand sanitizer to first responders with every order.
Also, Hydromer and N8 Medical partner to bring life-saving coated ET tubes for COVID-19 patients. Read more here.
As a globally trusted partner to companies of all sizes, Hydromer® has been offering specialty polymers and surface coating technologies, contract coating services, and custom-designed equipment for diverse applications since 1981. Our leading-edge solutions amplify products within many industries, including: medical devices, industrial plastics, biotechnology, aerospace and personal care. We help our partners introduce products to the market in less time while differentiating themselves from their competition. We’re agile and able to produce prototypes, as well as finished coated devices, with complex geometries, in volumes small to large.
Hydromer personifies innovation, driven by a team of exceptional Ph.D. chemists and innovators. We take pride in offering outstanding R&D, customer service, and tech support. Our company continually focuses on the future by developing innovative solutions comprised of more eco-friendly and sustainable approaches. We are an FDA registered, ISO 13485:2016 and ISO 9001:2015 certified production facility.
As the need for PPE and face masks become more prominent, the need for anti-fog coatings do as well. Anti-fog coatings allow users to have a clear visibility that is crucial in them caring for their patients or when patients need to communicate qwith healthcare workers. Hydromer’s Luxere® anti-fog coatings can provide long-lasting, enhanced anti-fog properties with some abrasion resistance, allowing healthcare workers to sustain a clear view, while protecting them against infections like COVID19. Let us coat your devices now to give your end users a better field of vision.
Hydromer is actively engaged in the fight against COVID-19 by scaling up manufacturing of our various hand sanitizers during the current extreme demand and short supply of those critical products. Hydromer offers a variety of sanitizer solutions, including a US FDA mandated “alcohol-based” sanitizer version, which is widely needed across the entire spectrum of healthcare, safety, first response and many other critical functions. We are actively seeking partnerships, suppliers and sources of alcohol to ensure a steady supply of hand sanitizers, to the healthcare market. We have also secured a special permit from the ATF (Bureau of Alcohol, Tobacco, Firearms).
Now you can partner with Hydromer® to distribute greener proven, anti-microbial sanitizer solutions to the public. Hydromer® offers a greener, more natural, antimicrobial solution to chemical and alcohol-based sanitizers. Our patented Carvacrol technology, Carvatech® is a formulation safe for use on skin and as a disinfectant on multi-surfaces. We offer this as either an ingredient or in a ready-to-use sanitizer version in gallon or barrel quantities quickly. Our formulation can also be licensed and/or privately labeled for your own manufacturing to meet the growing public demand. Learn how your company can be a solution to this epidemic, when sanitation gels and cleaners are running low by inquiring about Hydromer’s Carvatech® formulation.
To date, we have not had any issues with the coating and our firm plan is to continue using Hydromer whenever we need to process our devices. Solid vendor, definitely recommend.
Our office has been going through Hydromer for a while now. Fantastic customer service! Very high quality work!
They are a great company with superior products. You can’t beat the price either. Top quality and top notch products!
We needed to get our devices coated in a short time frame and they were accommodating to our needs. We appreciated how helpful they were. The coating was very high quality. It came out perfectly.
The entire team at Hydromer including the president himself, sales, engineering, manufacturing and quality assurance were outstanding in responding and delivering finished coated parts on-time.
The coating that Hydromer provides is noticeably better than any of the vendors we were looking at. Customer service has been excellent throughout this entire process. They were happy to accommodate us with any late minute requests and information.
The coating we required needed to have a degree of anti static properties and the great people over at Hydromer were able to guide us the right solution to our problem. The end result was a great product, with exceptional presentation.
It was clear that you recognized the importance of our device in saving lives. As such, you rapidly deployed Hydromer’s top scientists, focused and prioritized our project and allocated all necessary resources to solve the problem expediently.
In my interactions with Hydromer I have found a professional R&D partner, providing excellent service and fast response.
Hydromer, Inc. (OTC Pink: HYDI) announces today that Mr. Matt J. McGlon has joined the Hydromer team in the capacity of National and Key Accounts Sales Manager. Matt is a seasoned medical device Sales and Account Management professional with over fifteen years of experience. He has a proven track record of achieving aggressive sales growth and introducing new products and technologies in highly competitive markets. Matt has a comprehensive understanding of med-tech products and technologies in specialties such as Peripheral Vascular and Endoscopic Surgery, Interventional Radiology, Trauma Surgery, Interventional Cardiology, Orthopedics and Sports Medicine. Over the past 15 years, Matt has held key territory and account management positions at world class companies such as CR Bard (now Beckton Dickenson), Atrium Medical, Biomet Orthopedics, and Smith & Nephew Orthopedics, where he not only managed key territories, but also helped drive complex GPO/IDN negotiations. Matt’s academic background includes two BS degrees in Business Management and Marketing and in Exercise Science from Auburn University.
“With the biomaterial coatings market for medical devices projected to reach over $15 billion by 2021 and the flurry of new material science and substrates that customers need surface coatings for, we are very enthusiastic that Matt is bringing his extensive med-tech expertise to further expand our presence in this arena,” said Peter M. von Dyck, Hydromer’s CEO.
Innovating polymers and coatings since 1981, Hydromer, Inc. is a leading ISO 9001:2015 technology-focused company engaged in the business of inventing, developing, patenting, licensing, manufacturing and selling hydrophilic polymer based products for commercial markets including Medical Device, Pharmaceutical, Biotechnology, Industrial Plastics, Cosmetic and Personal Care. Hydromer also provides highly specialized medical coating services to industry through its FDA registered and ISO 13485:2016 certified Medical Products subsidiary.
For the latest information about Hydromer, Inc. and its products, please visit our web site at http://www.hydromer.com
Nikki Barnes Marketing Specialist (908) 722-5000 firstname.lastname@example.org
Hydromer, Inc. (OTC Pink: HYDI) announces today that Mr. Matt J. McGlon has joined the Hydromer team in the capacity of National and Key Accounts Sales Manager. Matt is a...Read more ›
Hydromer Inc. (OTC: HYDI) announced today it will be moving its operations to the Charlotte, North Carolina region. Hydromer’s current facilities in Branchburg, New Jersey,...Read more ›
Hydromer, Inc. (OTC: HYDI) announces the addition of two new members of its Operations and Financial team, as it continues to scale for growth in the rapidly increasing medical...Read more ›